Compare · BON vs CRON
BON vs CRON
Side-by-side comparison of Bon Natural Life Limited (BON) and Cronos Group Inc. (CRON): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BON and CRON operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CRON is the larger of the two at $1.13B, about 132.2x BON ($8.5M).
- CRON has hit the wire 5 times in the past 4 weeks while BON has been quiet.
- CRON has more recent analyst coverage (11 ratings vs 0 for BON).
- Company
- Bon Natural Life Limited
- Cronos Group Inc.
- Price
- -
- -
- Market cap
- $8.5M
- $1.13B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 5
- Recent ratings
- 0
- 11
Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Latest BON
- SEC Form 6-K filed by Bon Natural Life Limited
- SEC Form 3 filed by new insider Zhixiang Gao
- SEC Form 3 filed by new insider Chen Jing Veronica
- SEC Form 3 filed by new insider Hu Yongwei
- SEC Form 3 filed by new insider Xue Yingchun
- SEC Form 3 filed by new insider Ma Xin
- SEC Form 3 filed by new insider Wenjuan Chen
- SEC Form 3 filed by new insider Liu Jing
- SEC Form 3 filed by new insider Gao Jianjun
- BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives
Latest CRON
- Almonty Strengthens Board with Two Independent Directors and Announces Intention to Pursue a Secondary Listing on the Korean Exchange
- Officer Wagner Adam converted options into 20,242 shares, increasing direct ownership by 19% to 124,229 units (SEC Form 4)
- SEC Form 10-Q filed by Cronos Group Inc.
- Cronos Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cronos Group Reports 2026 Third Quarter Results
- SEC Form 4 filed by Cronos Group Inc.
- SEC Form 3 filed by Cronos Group Inc.
- SEC Form 8-K filed by Cronos Group Inc.
- Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
- Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season